- Home
- App-Analyse
- MyHealthPal Provider
- MyHealthPal Provider Vs. The eFACE
MyHealthPal Provider im Vergleich zu The eFACE Nutzung und Statistiken
MyHealthPal provides clinicians with a comprehensive tool to monitor and manage wound healing and provide predictive wound healing. MyHealthPal guides healthcare professionals through getting alerts on postoperative wound healing status. Disclaimer: This app is intended for use with clinicians’ supervision. The application is not, and is not intended, for use in the diagnosis or treatment or prevention of any disease. Users use this at their own risk, and health care providers should exercise their own professional judgment when using this app. This app is not intended to replace or add to any current procedure for wound monitoring or care in professional health care for humans.
- Apple App Store
- Kostenlos
- Medizin
Rang speichern
- -
Application designed to provide rapid quantitative and graphic depiction of facial function scores in patients suffering from unilateral facial paralysis, using visual analog scales. The instrument is divided into resting (static) readings, dynamic movement readings, and synkinesis (misrouting) scores.
During real-time examination of the patient, or afterwards from a video clip of facial movements, the app can be used to obtain clinician-rated scores for 16 separate facial function features. Graphs provide data regarding resting facial positions, and dynamic facial movements, and synkinesis features.
- Apple App Store
- Bezahlt
- Medizin
Rang speichern
- -
MyHealthPal Providervs. The eFACE Ranking-Vergleich
Vergleichen Sie MyHealthPal Provider den Ranking-Trend der letzten 28 Tage mit The eFACE
Rang
Keine Daten verfügbar
MyHealthPal Provider im Vergleich zu The eFACE Ranking im Ländervergleich
Vergleichen Sie MyHealthPal Provider den Ranking-Trend der letzten 28 Tage mit The eFACE
Keine Daten zum Anzeigen
Stellen Sie mit unserer kostenlosen Testversion Vergleiche mit jeder Website an
MyHealthPal Provider VS.
The eFACE
Dezember 23, 2024